File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: 96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection

Title96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection
Authors
Agarwal, KBrunetto, MSeto, WKWLim, YSFung, SMarcellin, PAhn, SHIzumi, NChuang, WLBae, HSharma, MJanssen, HPan, CCelen, MKFurusyo, NShalimar, DYoon, KTTrinh, HChan, HL
KeywordsBone safety
Chronic hepatitis B virus
Renal safety
Issue Date2018
PublisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep
Citation
Journal of Hepatology, 2018, v. 68, p. 672-681 How to Cite?
DOI: http://dx.doi.org/10.1016/j.jhep.2017.11.039
Persistent Identifierhttp://hdl.handle.net/10722/252125
ISSN
0168-8278
2021 Impact Factor: 30.083
2020 SCImago Journal Rankings: 7.112
ISI Accession Number ID
WOS:000427594900009

 

DC FieldValueLanguage
dc.contributor.authorAgarwal, K-
dc.contributor.authorBrunetto, M-
dc.contributor.authorSeto, WKW-
dc.contributor.authorLim, YS-
dc.contributor.authorFung, S-
dc.contributor.authorMarcellin, P-
dc.contributor.authorAhn, SH-
dc.contributor.authorIzumi, N-
dc.contributor.authorChuang, WL-
dc.contributor.authorBae, H-
dc.contributor.authorSharma, M-
dc.contributor.authorJanssen, H-
dc.contributor.authorPan, C-
dc.contributor.authorCelen, MK-
dc.contributor.authorFurusyo, N-
dc.contributor.authorShalimar, D-
dc.contributor.authorYoon, KT-
dc.contributor.authorTrinh, H-
dc.contributor.authorChan, HL-
dc.date.accessioned2018-04-11T02:00:34Z-
dc.date.available2018-04-11T02:00:34Z-
dc.date.issued2018-
dc.identifier.citationJournal of Hepatology, 2018, v. 68, p. 672-681-
dc.identifier.issn0168-8278-
dc.identifier.urihttp://hdl.handle.net/10722/252125-
dc.languageeng-
dc.publisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep-
dc.relation.ispartofJournal of Hepatology-
dc.subjectBone safety-
dc.subjectChronic hepatitis B virus-
dc.subjectRenal safety-
dc.title96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection-
dc.typeArticle-
dc.identifier.emailSeto, WKW: wkseto@hku.hk-
dc.identifier.authoritySeto, WKW=rp01659-
dc.identifier.doi10.1016/j.jhep.2017.11.039-
dc.identifier.pmid29756595-
dc.identifier.scopuseid_2-s2.0-85041127106-
dc.identifier.hkuros284775-
dc.identifier.volume68-
dc.identifier.spage672-
dc.identifier.epage681-
dc.identifier.isiWOS:000427594900009-
dc.publisher.placeNetherlands-
dc.identifier.issnl0168-8278-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats